GANX EPS Estimates
Gain Therapeutics, Inc.
$1.33
+$0.01(+0.76%)
31
Overall
40
Value
30
Tech
23
Quality
Market Cap
$58.05M
Volume
501.27K
52W Range
$1.53 - $4.34
Target Price
$7.20
GANX EPS estimates: the consensus estimate for Gain Therapeutics, Inc.'s current fiscal year is -$0.50 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
GANX EPS Estimates
- EPS estimate, current quarter
- $-0.13
- EPS estimate, next quarter
- $-0.13
- EPS estimate, current year
- $-0.50
- EPS estimate, next year
- $-0.55
- EPS growth, 3-year
- +25.58%
| Fiscal year | EPS |
|---|---|
| 2025 | $-0.61 |
| 2024 | $-0.89 |
| 2023 | $-1.71 |
| 2022 | $-1.48 |
| 2021 | $-1.37 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | GANX | $1.33 | +0.8% | 501.27K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |